Stop Kicking Me!

Drug to calm sleep-robbing leg syndrome OKd by FDA

Earlier this month, the FDA gave the green light to pharmaceutical company GlaxoSmithKline to market Requip for moderate-to- severe RLS. The drug is a so-called dopamine-agonist, a class of medications commonly used in much higher doses to treat symptoms of Parkinson's disease, although doctors stress that the two conditions are unrelated.